Philip Morris Beats Q1 Earnings by 27 Cents as IQOS Drives 16% Profit Growth

Philip Morris International (NYSE: PM) delivered first-quarter adjusted earnings per share of $1.96, crushing Wall Street expectations of $1.69 by 27 cents — a 16% beat that sent a clear message about the company's smoke-free transformation.

Key Numbers

The tobacco giant's adjusted EPS grew 16% year-over-year to $1.96, or 5.3% excluding currency benefits. On a reported basis, earnings declined 9.3% to $1.56 per share, impacted by a non-cash fair value adjustment on the company's minority stake in India.

Revenue climbed 9.1% to $10.1 billion, with organic growth of 2.7% after stripping out currency effects. The standout performer was the smoke-free segment, which surged 24.7% to $3.8 billion and now represents 43% of total net revenues — up 1.3 percentage points from last year.

Gross profit expanded 10.1% to $6.9 billion, with margins improving 60 basis points to 68.1% driven by strong pricing power and the growing mix of higher-margin smoke-free products.

Perhaps most significantly, IQOS has now surpassed Marlboro to become Philip Morris's #1 nicotine brand in markets where it's present, capturing 10.9% of combined cigarette and heated tobacco unit (HTU) volumes — a gain of 1.7 percentage points.

What Management Said

CEO Jacek Olczak struck a confident tone, calling out "an outstanding delivery from IQOS driving very good growth for the group against a strong prior-year comparison." He emphasized the company is "well positioned to continue delivering best-in-class performance in 2026" based on "excellent broad-based momentum in the international smoke-free business."

Management highlighted several geographic bright spots. In Japan, IQOS maintained nearly 70% share of the heat-not-burn category, with HTU products reaching approximately 53% of total nicotine consumption nationally. IQOS's share of total nicotine grew 2.7 percentage points to a record 34.9%.

The company noted Taiwan as "the most successful major launch market to date," with IQOS reaching almost 6% national share in March. European performance remained solid despite "ongoing disruptions in Ukraine and the initial impact of the characterizing flavor ban in Poland."

On the U.S. front, management acknowledged challenges with ZYN nicotine pouches, citing "an uneven competitive landscape where we do not yet have access to all of the most dynamic strength and flavor segments." Despite a 23.5% decline in ZYN shipments to 2.3 billion pouches, underlying offtake grew 10% according to Nielsen data, with the shipment decline attributed to expected inventory normalization.

Management reaffirmed its commitment to innovation, preparing to launch ZYN ULTRA pending FDA review as part of the nicotine pouch pilot program.

What to Watch

Philip Morris updated its full-year 2026 guidance, projecting adjusted EPS of $8.36 to $8.51, representing growth of 10.9% to 12.9%. Excluding currency benefits of $0.25, the company expects 7.5% to 9.5% growth on a constant currency basis.

Key assumptions underpinning the guidance include high-single digit growth in smoke-free product shipments, organic revenue growth of 5% to 7%, and operating income growth of 7% to 9% on an organic basis. The company expects operating cash flow of approximately $13.5 billion.

Investors should monitor several critical metrics going forward. First, the pace of IQOS adoption outside established markets — the "outside Europe and Japan" segment grew adjusted in-market sales by an impressive 19.4%. Second, ZYN's ability to gain share in the U.S. as new product variants launch and the competitive landscape evolves. The company needs to reverse the current shipment declines and translate the 10% offtake growth into stronger financial performance.

Third, watch for impacts from regulatory changes, particularly the characterizing flavor bans in Europe. Poland's ban went into effect in January, and management noted that excluding markets with recent flavor bans, European HTU volumes would have grown around 8% versus the reported 5.4%.

The Middle East conflict remains a wildcard. While management described the Q1 impact as "small," they've factored increased transport and energy costs into their guidance while acknowledging the situation's uncertainty.

Finally, keep an eye on the company's debt reduction progress. Philip Morris is targeting a net debt to adjusted EBITDA ratio close to 2.0x by year-end, continuing its deleveraging trajectory without share repurchases.

The quarter demonstrates Philip Morris's smoke-free transformation is gaining serious momentum, with IQOS's symbolic overtaking of Marlboro marking a historic shift. While traditional cigarette volumes declined 5.1% as expected, the 11.9% growth in smoke-free volumes and expanding margins validate the strategic pivot. The key question for investors: Can this momentum sustain as regulatory pressures mount and competition intensifies in both heated tobacco and nicotine pouches?

*StockCliff Research*

*Source: Philip Morris International Q1 2026 Earnings Release filed with the SEC*